Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raquel Duarte

Showing results (121-130 of 292) with videos related to

Pageof 30
Sort By:
Pulmonology|October 13, 2018
Portuguese in vitro antibiotic susceptibilities favor current nontuberculous mycobacteria treatment guidelinesVera Durão, Anabela Silva, Rita Macedo, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 27, 2020
Ki67 Immunohistochemistry Quantification in Breast Carcinoma: A Comparison of Visual Estimation, Counting, and ImmunoRatioEunice J van den Berg, Raquel Duarte, Caroline Dickens, et al.
Social Science & Medicine (1982)|July 19, 2025
Mapping risk and protective factors in tuberculosis-related stigma: a scoping reviewMariana Vieira, Pedro Barbosa, João Pedro Ramos, et al.
International Journal of Nephrology|May 16, 2020
Biomarkers for Diagnosis and Prediction of Outcomes in Contrast-Induced NephropathyJustor Banda, Raquel Duarte, Therese Dix-Peek, et al.
BMC Infectious Diseases|July 3, 2019
A nationwide study of multidrug-resistant tuberculosis in Portugal 2014-2017 using epidemiological and molecular clustering analysesOlena Oliveira, Rita Gaio, Carlos Carvalho, et al.
Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia|June 18, 2025
Exploring perspectives on the benefits of a tuberculosis short-treatment regimen: a cross-sectional study on treatment experiences and perceptionsFernando Pereira da Silva, João Pedro Ramos, Pedro Barbosa, et al.
Breathe (Sheffield, England)|October 13, 2023
Treatment-shortening regimens for tuberculosis: updates and future prioritiesFrancesca Saluzzo, Victor Abiola Adepoju, Raquel Duarte, et al.
Breathe (Sheffield, England)|September 18, 2023
Building bridges: multidisciplinary teams in tuberculosis prevention and careJoão Pedro Ramos, Mariana Vieira, Cátia Pimentel, et al.
Kidney International Reports|July 31, 2024
Corrigendum to "WCN24-1105 PHARMACOGENETIC RISK FACTORS FOR TENOFOVIR-INDUCED KIDNEY TUBULAR DYSFUNCTION AMONG HIV-POSITIVE ADULT NIGERIANS" [<i>Kidney International Reports</i> Volume 9, Issue 4, Supplement, April 2024, Page S339]Muzamil Hassan, Raquel Duarte, Victor Mabayoje, et al.
Breathe (Sheffield, England)|January 29, 2026
Management of adverse events in TB care and active TB drug safety monitoringShamsuddeen Yusuf Ma'aruf, Aparna Sharma, Shannon Fox, et al.
Pageof 30

Showing results (121-130 of 292) with videos related to

Sort By:
Pageof 30
Pulmonology|October 13, 2018
Portuguese in vitro antibiotic susceptibilities favor current nontuberculous mycobacteria treatment guidelinesVera Durão, Anabela Silva, Rita Macedo, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 27, 2020
Ki67 Immunohistochemistry Quantification in Breast Carcinoma: A Comparison of Visual Estimation, Counting, and ImmunoRatioEunice J van den Berg, Raquel Duarte, Caroline Dickens, et al.
Social Science & Medicine (1982)|July 19, 2025
Mapping risk and protective factors in tuberculosis-related stigma: a scoping reviewMariana Vieira, Pedro Barbosa, João Pedro Ramos, et al.
International Journal of Nephrology|May 16, 2020
Biomarkers for Diagnosis and Prediction of Outcomes in Contrast-Induced NephropathyJustor Banda, Raquel Duarte, Therese Dix-Peek, et al.
BMC Infectious Diseases|July 3, 2019
A nationwide study of multidrug-resistant tuberculosis in Portugal 2014-2017 using epidemiological and molecular clustering analysesOlena Oliveira, Rita Gaio, Carlos Carvalho, et al.
Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia|June 18, 2025
Exploring perspectives on the benefits of a tuberculosis short-treatment regimen: a cross-sectional study on treatment experiences and perceptionsFernando Pereira da Silva, João Pedro Ramos, Pedro Barbosa, et al.
Breathe (Sheffield, England)|October 13, 2023
Treatment-shortening regimens for tuberculosis: updates and future prioritiesFrancesca Saluzzo, Victor Abiola Adepoju, Raquel Duarte, et al.
Breathe (Sheffield, England)|September 18, 2023
Building bridges: multidisciplinary teams in tuberculosis prevention and careJoão Pedro Ramos, Mariana Vieira, Cátia Pimentel, et al.
Kidney International Reports|July 31, 2024
Corrigendum to "WCN24-1105 PHARMACOGENETIC RISK FACTORS FOR TENOFOVIR-INDUCED KIDNEY TUBULAR DYSFUNCTION AMONG HIV-POSITIVE ADULT NIGERIANS" [<i>Kidney International Reports</i> Volume 9, Issue 4, Supplement, April 2024, Page S339]Muzamil Hassan, Raquel Duarte, Victor Mabayoje, et al.
Breathe (Sheffield, England)|January 29, 2026
Management of adverse events in TB care and active TB drug safety monitoringShamsuddeen Yusuf Ma'aruf, Aparna Sharma, Shannon Fox, et al.
Pageof 30